WHO ICTRP trial
A randomized controlled study of intraperitoneal hyperthermic perfusion…
ChiCTR2200056545 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200056545 |
|---|---|
| Public title | A randomized controlled study of intraperitoneal hyperthermic perfusion chemotherapy (HIPEC) combined with intraperitoneal perfusion chemotherapy for gastric cancer with peritoneal metastasis |
| Scientific title | A randomized controlled study of intraperitoneal hyperthermic perfusion chemotherapy (HIPEC) combined with intraperitoneal perfusion chemotherapy for gastric cancer with peritoneal metastasis |
| Primary sponsor | Liaoning Provincial Cancer Hospital/Affiliated Cancer Hospital of Dalian University of Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Treatment study |
| Phase | 2 |
| Countries | China |
| Conditions | gastric cancer |
| Interventions | Group 1:Albumin binding paclitaxel+intraperitoneal hyperthermic perfusion chemotherapy;Group 2:Solvent paclitaxel+intraperitoneal hyperthermic perfusion chemotherapy;Group 3:Intravenous and intraperitoneal infusion of solvent paclitaxel… |
| Registration date | Feb 7, 2022 |
| Target size | Group 1:30;Group 2:30;Group 3:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: